Distinct signaling pathways of microtubule inhibitors - vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively

被引:46
作者
Kolomeichuk, Sergey N. [1 ]
Terrano, David T. [1 ]
Lyle, Christopher S. [1 ]
Sabapathy, Kanaga [2 ]
Chambers, Timothy C. [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Natl Canc Ctr, Mol Carcinogenesis Lab, Singapore, Singapore
关键词
apoptosis; c-Jun/AP-1; JNK; Taxol; vinblastine;
D O I
10.1111/j.1742-4658.2008.06349.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vinblastine and paclitaxel (Taxol) are widely used chemotherapeutic drugs that inhibit the normal function of microtubules causing mitotic arrest and cell death. Despite these similarities, the signaling pathways that mediate and regulate cell death induced by these agents remain incompletely understood. The purpose of this study was to directly compare the two drugs in terms of their ability to activate components of the c-Jun N-terminal protein kinase (JNK) pathway, and to establish the importance of these signaling events in apoptosis induced by these agents. We show that both drugs induce mitotic arrest and subsequent apoptotic cell death with highly similar kinetics and that both activate JNK and induce c-Jun protein and c-jun mRNA expression. Surprisingly, vinblastine induced c-Jun phosphorylation and c-jun transcriptional activation, although Taxol failed to do so. However, inhibition of JNK or an absence of JNK protected against both vinblastine- and Taxol-induced cell death. These results suggest that although JNK activation plays an important role in cell death induced by both agents, vinblastine and Taxol differ markedly with respect to signaling downstream of JNK, with AP-1-dependent and -independent mechanisms, respectively. In addition, these results show, contrary to popular belief, that JNK activation is not necessarily accompanied by c-Jun activation, and thus c-Jun is not an obligate substrate of JNK.
引用
收藏
页码:1889 / 1899
页数:11
相关论文
共 25 条
[1]   THE JUN PROTO-ONCOGENE IS POSITIVELY AUTOREGULATED BY ITS PRODUCT, JUN/AP-1 [J].
ANGEL, P ;
HATTORI, K ;
SMEAL, T ;
KARIN, M .
CELL, 1988, 55 (05) :875-885
[2]  
[Anonymous], 1989, SELECTED PAPERS C R
[3]   Microtubule-targeted anticancer agents and apoptosis [J].
Bhalla, KN .
ONCOGENE, 2003, 22 (56) :9075-9086
[4]   Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases [J].
Bogoyevitch, Marie A. ;
Kobe, Bostjan .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2006, 70 (04) :1061-+
[5]   The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide [J].
Brantley-Finley, C ;
Lyle, CS ;
Du, LH ;
Goodwin, ME ;
Hall, T ;
Szwedo, D ;
Kaushal, GP ;
Chambers, TC .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (03) :459-469
[6]   Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity - Evidence that mitotic Bcl-2 phosphorylation is JNK-independent [J].
Du, LH ;
Lyle, CS ;
Obey, TB ;
Gaarde, WA ;
Muir, JA ;
Bennett, BL ;
Chambers, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11957-11966
[7]   Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy [J].
Fan, MY ;
Chambers, TC .
DRUG RESISTANCE UPDATES, 2001, 4 (04) :253-267
[8]  
Fan MY, 2001, CANCER RES, V61, P4450
[9]   Stress-activated kinases regulate protein stability [J].
Fuchs, SY ;
Fried, VA ;
Ronai, Z .
ONCOGENE, 1998, 17 (11) :1483-1490
[10]   c-Jun and the transcriptional control of neuronal apoptosis [J].
Ham, J ;
Eilers, A ;
Whitfield, J ;
Neame, SJ ;
Shah, B .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1015-1021